Prohibitin 1 regulates mtDNA release and downstream inflammatory responses

Hao Liu1,2,3, Hualin Fan2,4, Pengcheng He5,6,7,8

  • 1Qingyuan People's Hospital, The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan, China.

The EMBO Journal
|October 17, 2022
PubMed

Insights

Mitochondrial DNA (mtDNA) release into the cytosol triggers inflammation. Prohibitin 1 (PHB1) regulates this release by controlling inner mitochondrial membrane permeability, impacting immune responses.

Area of Science:

  • Immunology
  • Cell Biology
  • Mitochondrial Biology

Background:

  • Cytosolic exposure of mitochondrial DNA (mtDNA) activates innate immunity.
  • Mechanisms of mtDNA translocation across the inner mitochondrial membrane remain unclear.

Purpose of the Study:

  • To elucidate the role of prohibitin 1 (PHB1) in regulating mitochondrial inner membrane permeability and mtDNA release.
  • To investigate the link between PHB1, mitochondrial integrity, and inflammatory responses.

Main Methods:

  • Investigated PHB1 function in macrophages and knockout mouse models (Phb1MyeKO).
  • Analyzed interleukin-1β (IL-1β) levels in serum and cells.
  • Assessed inflammatory responses and mtDNA release in PHB1-deficient cells.
  • Utilized pharmacological inhibitors of mitochondrial permeability transition pore (mPTP) and VDAC oligomerization.

Main Results:

  • Loss of PHB1 disrupts mitochondrial integrity and function, leading to increased mtDNA release.
  • PHB1 deficiency in macrophages and mice correlates with elevated IL-1β levels and heightened inflammatory responses.
  • Inflammatory stresses downregulate PHB1 expression, promoting mtDNA release.
  • PHB1 normally restrains mPTP opening by interacting with AFG3L2 and SPG7; PHB1 loss enhances this interaction, causing mPTP opening and mtDNA release.

Conclusions:

  • PHB1 is a critical regulator of inner mitochondrial membrane permeability, controlling mtDNA release and subsequent inflammatory signaling.
  • Dysregulation of PHB1 contributes to inflammatory conditions, as observed in sepsis models.
  • Targeting PHB1 or mPTP could offer therapeutic strategies for inflammatory diseases driven by mtDNA release.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.6K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.0K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.5K